MX2009006178A - Vacuna contra salmonela. - Google Patents

Vacuna contra salmonela.

Info

Publication number
MX2009006178A
MX2009006178A MX2009006178A MX2009006178A MX2009006178A MX 2009006178 A MX2009006178 A MX 2009006178A MX 2009006178 A MX2009006178 A MX 2009006178A MX 2009006178 A MX2009006178 A MX 2009006178A MX 2009006178 A MX2009006178 A MX 2009006178A
Authority
MX
Mexico
Prior art keywords
salmonella
present
vaccine
diluent
pharmaceutically
Prior art date
Application number
MX2009006178A
Other languages
English (en)
Inventor
Francois-Xavier Le Gros
Stephane Lemiere
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39281421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006178(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX2009006178A publication Critical patent/MX2009006178A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se relaciona con el campo de vacunación contra Salmonela en animales, particularmente aves. La presente invención también abarca kits y el uso de vacunas o composiciones inmunogénicas de Salmonela. La presente invención además se relaciona con métodos y composiciones que comprenden al menos una primo-administración de una vacuna o composición inmunogénica atenuadas, que comprende un excipiente, diluyente o vehículo farmacéuticamente o veterinariamente aceptables y al menos una cepa de Salmonela atenuada que se administra a un ave al menos antes de una administración de refuerzo de una vacuna o composición inmunogénica atenuadas, que comprenden un excipiente, diluyente o vehículo farmacéuticamente o veterinariamente aceptables y al menos una cepa de Salmonela inactivad.
MX2009006178A 2006-12-11 2007-12-10 Vacuna contra salmonela. MX2009006178A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86952406P 2006-12-11 2006-12-11
PCT/US2007/086979 WO2008073891A2 (en) 2006-12-11 2007-12-10 Salmonella vaccine in poultry

Publications (1)

Publication Number Publication Date
MX2009006178A true MX2009006178A (es) 2009-07-22

Family

ID=39281421

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006178A MX2009006178A (es) 2006-12-11 2007-12-10 Vacuna contra salmonela.

Country Status (21)

Country Link
US (1) US8062645B2 (es)
EP (1) EP2099479B1 (es)
JP (1) JP5229637B2 (es)
CN (1) CN101578108A (es)
AU (1) AU2007333169B2 (es)
BR (1) BRPI0720111B1 (es)
CA (1) CA2672026C (es)
CO (1) CO6190623A2 (es)
DK (1) DK2099479T3 (es)
ES (1) ES2398598T3 (es)
HK (1) HK1134783A1 (es)
HR (1) HRP20130065T1 (es)
MX (1) MX2009006178A (es)
NZ (1) NZ577610A (es)
PL (1) PL2099479T3 (es)
PT (1) PT2099479E (es)
RU (2) RU2596208C2 (es)
SI (1) SI2099479T1 (es)
UA (1) UA100370C2 (es)
WO (1) WO2008073891A2 (es)
ZA (1) ZA200904060B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
FR2920295B1 (fr) * 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
WO2011019134A2 (ko) * 2009-08-11 2011-02-17 전북대학교산학협력단 살모넬라 변이균주를 포함하는 가금티푸스 예방용 백신 조성물
EP2528620B1 (en) * 2010-01-28 2019-06-05 Universiteit Gent Salmonella vaccine
WO2013034687A1 (en) 2011-09-09 2013-03-14 Universität Bern Verwaltungsdirektion Avibacterium paragallinarum rtx toxin
EP2829281B1 (en) 2012-03-22 2019-01-16 KM Biologics Co., Ltd. Lps vaccine
WO2014064236A1 (en) * 2012-10-26 2014-05-01 Intervet International B.V. Cross-protecting salmonella vaccines
ES2776429T3 (es) * 2012-12-07 2020-07-30 Elanco Tiergesundheit Ag Preparación de vacunas vivas
RU2683027C2 (ru) 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
CN103197078B (zh) * 2013-03-28 2015-04-08 扬州大学 鸡白痢沙门菌分泌性蛋白SpiC的用途
US20150359880A1 (en) * 2014-06-16 2015-12-17 Biomune Company Dual adjuvant vaccine compositions, preparation and uses
CN105031635B (zh) * 2015-04-03 2018-11-30 江苏省家禽科学研究所 一种鸡白痢沙门氏菌灭活疫苗的制备方法及其应用
CN112649606A (zh) * 2020-12-16 2021-04-13 江苏立华牧业股份有限公司 一种基于鸡白痢沙门氏菌x蛋白包被的抗体elisa检测方法
KR102632608B1 (ko) * 2021-03-11 2024-02-01 서울대학교산학협력단 약독화된 살모넬라 갈리나룸 생균 및 사균을 포함하는 가금티푸스 예방용 백신 조성물
BR112023020563A2 (pt) * 2021-04-05 2023-12-19 Univ Maryland Bactérias modificadas, método, formulação de vacina, e, artigo de manufatura

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3919411A (en) 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
GB9007194D0 (en) 1990-03-30 1990-05-30 Wellcome Found Live vaccines
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB9615022D0 (en) 1996-07-17 1996-09-04 Mini Agriculture & Fisheries Vaccine preparations
AU2144499A (en) 1998-01-22 1999-08-09 Vrije Universiteit Brussel Live attenuated salmonella vaccine
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2776928B1 (fr) 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
US6645740B1 (en) 1999-06-10 2003-11-11 Merial Limited Nucleic acids encodings equine GM-CSF
SK287400B6 (sk) 1999-09-25 2010-08-09 University Of Iowa Research Foundation Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
EP1267899B1 (en) * 2000-03-17 2005-08-03 Pharmacia & Upjohn Company LLC Ssa inactivated salmonella vaccines
US6605285B2 (en) * 2000-03-29 2003-08-12 G.B. Pant University Of Agriculture & Technology Vaccine for protection of poultry against salmonellosis and a process for preparing the same
AU2003245416A1 (en) 2002-06-07 2004-04-30 University Of Florida Endodontic files made using bulk metallic glasses
US6933957B2 (en) * 2002-09-24 2005-08-23 Ricoh Company, Ltd. Pixel clock generation apparatus, pixel clock generation method, and image forming apparatus capable of correcting main scan dot position shift with a high degree of accuracy
EP1651265B1 (en) 2003-07-24 2008-04-23 Merial Limited Vaccine formulations comprising an oil-in-water emulsion
CA2570156C (en) 2004-06-04 2014-09-30 Merial Limited Needle-free administration of felv vaccines

Also Published As

Publication number Publication date
PT2099479E (pt) 2013-01-31
UA100370C2 (uk) 2012-12-25
BRPI0720111B1 (pt) 2018-05-29
EP2099479B1 (en) 2012-11-07
US8062645B2 (en) 2011-11-22
JP2010512412A (ja) 2010-04-22
AU2007333169B2 (en) 2013-06-13
CN101578108A (zh) 2009-11-11
HK1134783A1 (en) 2010-05-14
DK2099479T3 (da) 2013-01-14
CA2672026A1 (en) 2008-06-19
RU2009126604A (ru) 2011-01-20
SI2099479T1 (sl) 2013-02-28
ZA200904060B (en) 2010-04-28
JP5229637B2 (ja) 2013-07-03
WO2008073891A3 (en) 2008-08-28
BRPI0720111A2 (pt) 2014-01-14
RU2455023C2 (ru) 2012-07-10
CO6190623A2 (es) 2010-08-19
US20080220022A1 (en) 2008-09-11
RU2596208C2 (ru) 2016-08-27
PL2099479T3 (pl) 2013-03-29
CA2672026C (en) 2016-02-02
HRP20130065T1 (hr) 2013-02-28
WO2008073891A2 (en) 2008-06-19
EP2099479A2 (en) 2009-09-16
NZ577610A (en) 2011-08-26
ES2398598T3 (es) 2013-03-20
AU2007333169A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
MX2009006178A (es) Vacuna contra salmonela.
MX2008009929A (es) Vacuna a base de levadura para inducir una respuesta inmune.
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
PH12014501836A1 (en) Novel adjuvant compositions
WO2008039408A3 (en) Live bacterial vaccines for viral infection prophylaxis or treatment
SI1954308T1 (sl) Stabilizatorji za liofilizirana cepiva
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
MX338898B (es) Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio.
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
MX351380B (es) Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
WO2017214596A8 (en) Compositions and methods for preventing and treating zika virus infection
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
NZ618158A (en) Compositions and methods for administration of vaccines against dengue virus
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
PH12018501368A1 (en) M hyo multivalent vaccine and uses thereof
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
WO2007098717A3 (es) Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
NO20090290L (no) Polyvalent vaksine mot salmonid alfavirusinfeksjoner
CA2956065C (en) Immunogenic lhrh composition and use thereof in pigs
WO2011074006A3 (en) Vaccine composition
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella

Legal Events

Date Code Title Description
FG Grant or registration